KNOW WHAT YOU OWN & WHY YOU OWN IT~! *(Pete Lynch)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ya darn tootin..
Yes.. Indeed
That settlement is coming....
We will be on a sweet ride for sure..
Awesome... Bring them on..
Awesome loading today... Need some people to sell me some of their shares..
"Load n Hold" ....
Arrrrr... Got me some of this
This be mighty fine ...
"Yes Sir.!!! Ride out this fine storm and we shall see clearer skies..
Its coming and she is holding it's own @ these levels.
$SFOR
Yes...I agree
This is just revving up for that run upwards.. When those lawsuits come through.. "BOOM"
$SFOR
Agree
The volume suggest manipulation...
The ps dropped too sharply without extreme heavy dumping..
JMO
$SFOR
OMG ..!!!! I got my *SELL ORDER submitted.
"NOT" LOL
$SFOR
Oooooops.. Wrong board.. My apologies.. Yup.. Your right on that one
Wishful thinking on your part.. LOL
This hasn't even started yet...
$SFOR
What about the r/s?
Made to look horrible on purpose... Shaking the tree.. It works
$SFOR
Either way... It is coming.
This is headed for a "SONIC BOOM"..
$SFOR
Interesting..
The volume suggests an r/s is needed terribly here...
What a soup pile.. This one is like erbb.. LOL
You are such a wonderful man... Thank you so much for this warning... I see from your posts you have been protecting investors for quite sometime... You sir are truly an angel? Keep up the good work..
Thought this was going to move? I guess I will hang onto my sfor.
Keeping this on my radar.
Patience grasshopper... It's coming..
Go!! $SFOR
Anything is possible with these sub-pennies...
Possible..
Taking profits is healthy..
"Profit" sharks are eating... LOL
Good action here...
The anticipation is killing me...
Got's to load more for sure.
Upwards we shall head..
$SFOR
"Yes.. This will explode very soon..
We are headed onward n upward.
$SFOR
Getting pretty dry...
$MARI $1.84
May 24, 2017
Maricann Group Breaks Ground on 217K Sq. Ft. Greenhouse Expansion
Published by NCV Newswire
Visit the Maricann Group Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
maricann-green-house-expansion
Maricann Laying Down Foundations For More Growth
Licensed producer of cannabis is significantly expanding its growing facility, adding considerable scale to operations
TORONTO, May 24, 2017 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (OTC: MRRCF) (“Maricann” or the “Company”), a low cost, greenhouse producer of medical cannabis with market leading technological differentiation, is laying down the foundations today for more growth as it breaks ground for its expanding cultivation and production facility in Langton, Ontario.
Having recently listed publicly, we are now setting the stage for our ongoing physical expansion by way of a major enlargement of our Langton growing facility. We’re very proud to formally break ground of the first 217,000 sq. ft. of an overall 817,000 sq. ft. greenhouse facility expansion. This expanding facility will give us the scale we need to become one of the world’s leading vertically integrated cannabis companies.
ben ward maricann groupBen Ward, CEO of Maricann
Maricann originally acquired an 8,000 square foot growing operation in Langton in 2013. Since that time, Maricann has expanded its facility to 44,000 square feet, in which the company currently cultivates, processes and distributes medical cannabis. The new phase of additional construction underway will significantly increase the existing facility’s size.
When Phase 1 is complete in the fall of 2017:
The expanded Langton facility will be approximately 217,000 square feet, an increase of approximately 833% to the existing domestic facility.
This expansion increase will drive $80 million in additional annual revenues
Yield and production will increase 500%, with production of more than 20,000 kilograms by the end of the first year of the expanded facility.
Maricann Site plan
Phase 2, which will start in fourth quarter of 2017, will add an additional 300,000 square feet, an increase of 110% to the same facility, driving even more scale efficiencies.
“Our local team of experts from the food, pharmaceutical and construction sectors help us grow high-quality cannabis plants in Norfolk County, a region widely recognized as Ontario’s garden,” said Jeff Ayotte, Senior Director of Project Management Office. “Our highly energy-efficient growing facility will be operated with low-cost energy supply from both natural gas cogeneration and our active natural gas well on-site. It will be world class once it’s done, building on our deep roots both in the area and in the industry.”
Maricann Milestones
April 2013, Maricann Inc. is founded in Langton, Ontario, a well-established agricultural region in southwestern Ontario
March 2014, earned Health Canada licence to cultivate plants
December 2014, earned Health Canada licence to sell dried cannabis
January 2015, first dried cannabis sale
September 2016, earned Health Canada licence to sell cannabis extracts
October 2016, first sale of extracted cannabis
December 2016, raised $22 million in capital
January 2017, commenced sale of clones
February 2017, raised $10 million in capital
April 24, 2017, first day of trading
April 28, 2017, announces Advisory Board of German subsidiary
May 24, groundbreaking of expanding Langton facility
About Maricann
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Langton, Ontario, where it operates a cultivation, marijuana extraction and distribution business under federal licence from the Government of Canada. Maricann, which has federal licences to cultivate, process and distribute cannabis, services a patient base with more than 3,000 active patients.
www.maricann.ca
Original press release: https://globenewswire.com/news-release/2017/05/24/995709/0/en/Maricann-Laying-Down-Foundations-For-More-Growth.html
Ouch..
Need "volume" before Clay shows up...
$SFOR
This Stock is in serious trouble...
"The dumping continues"
It's possible it may see the triples?
Hmmmmm
LOL
No kidding... It's getting hard to load below .0137
This stock is getting ready to pop soon...
$SFOR
This is a scam..!! "Crooks"
$MARI $1.75 MJ Growing Facility
https://www.maricann.com/
$MARI $1.75
https://www.maricann.com/
?$C.MARI $1.75... Marijuana growing facility.. Discount price "Check it out... ?
After Germany announced plans to legalize medical cannabis at the federal level, there was significant increase in the number of companies focused on this market.
The expansion makes complete sense and we expect to see the number of firms levered to the German medical cannabis market continue to increase.
Germany has the largest population in the European Union and registered patients will have their medical cannabis covered by insurance. These factors combined with Germany being a cannabis friendly country (more than 22% of adults have tried cannabis) lead us to expect a high patient adoption rate.
Although Germany began to allow access to medical cannabis in 2005, domestic production does not yet exist and the country relies solely on imported products. This has created a multi-billion-dollar opportunity for international cannabis producers and has made Germany a very attractive market for cannabis companies.
Despite these positive characteristics, there are significant barriers to enter the German medical cannabis market. The country imposes very high standards for imports from a quality and consistency standpoint and a complex regulatory environment for importing and distributing cannabis.
These high barriers to entry have not deterred potential producers and the number of firms (especially Canadian producers) trying to enter the market continues to increase. The reason why Canada is positioned to capitalize on this market is because they already operate under Health Canada’s stringent rules and regulations.
Cronos Products are Sold out of 200+ Pharmacies
Since October, Cronos Group has been distributing cannabis to Germany via its wholly owned subsidiary, Peace Naturals Project Inc.
In an interview with Benzinga, Cronos Group CEO Mike Gorenstein said, “We see Germany and other places in Europe as extremely attractive [markets] because cannabis is treated as a medicine. Like any other medicine, you receive a prescription for it from your doctor, and insurance is mandated to cover it.”
At the time of this interview, Gorenstein said that roughly 200 pharmacies in the European country currently sell their products. This is a very attractive aspect of the company and we expect to see this number increase as the market continues to mature and grow.
A Canadian Cannabis Producer to Watch
In late 2016, leading Canadian medical cannabis producer Canopy Growth (TWMJF) (CGC.TO) acquired MedCann GmbH Pharma and Nutraceuticals, a German-based pharmaceutical distributor that has placed Tweed-branded cannabis strains in German pharmacies. MedCann is federally licensed by the German Health Ministry to import, manufacture and distribute medical cannabis products.
Canopy's various production sites have a track record of producing consistent strains that yield reliable cannabinoid profiles harvest after harvest. This was an important aspect of the due diligence process as such consistency is a federal requirement for cannabis exports entering Germany.
Maricann Goes Public and Offers Leverage to Germany
Last week, Maricann Group (MARI.CN: CSE) secured $42.5 million in non-dilutive financing to further expand production in Germany. The capital came from a Vancouver-based firm that provides non-equity financing solutions for cannabis producers. In return, Maricann will provide the company the right to purchase 20% of production at an all-in cost plus 10% from this expansion in Germany.
Maricann will use the capital for its 150,000-sq. ft. expansion at its Ebersbach Facility and an additional 250,000 sq. ft. in a two-tiered cultivation plan. The capital will also be used for an outdoor hemp farm for cannabis that is high in cannabidiol (CBD).
The Ebersbach facility was built 20 years ago and is comprised of multiple individual clean rooms. The facility will not require too much capital to revamp and the company said the infrastructure needed to grow cannabis in an indoor secured environment is already in place.
In late April, Maricann commenced trading on the Canadian Securities Exchange. A few days later the company announced an Advisory Board for its German subsidiary. This is a company to watch. Maricann is a vertically integrated Canadian producer and distributor of medical cannabis. Since its inception, the company has been servicing a patient base of 8,000+ total registered patients.
https://technical420.com/cannabis-article/3-ways-capitalize-german-cannabis-market
Read more at http://www.stockhouse.com/companies/bullboard?symbol=c.mari&postid=26218004#jswfOm59xiIV5ZYq.99
?$C.MARI $1.75... Marijuana growing facility.. Very low float "Discount price "Check it out...
After Germany announced plans to legalize medical cannabis at the federal level, there was significant increase in the number of companies focused on this market.
The expansion makes complete sense and we expect to see the number of firms levered to the German medical cannabis market continue to increase.
Germany has the largest population in the European Union and registered patients will have their medical cannabis covered by insurance. These factors combined with Germany being a cannabis friendly country (more than 22% of adults have tried cannabis) lead us to expect a high patient adoption rate.
Although Germany began to allow access to medical cannabis in 2005, domestic production does not yet exist and the country relies solely on imported products. This has created a multi-billion-dollar opportunity for international cannabis producers and has made Germany a very attractive market for cannabis companies.
Despite these positive characteristics, there are significant barriers to enter the German medical cannabis market. The country imposes very high standards for imports from a quality and consistency standpoint and a complex regulatory environment for importing and distributing cannabis.
These high barriers to entry have not deterred potential producers and the number of firms (especially Canadian producers) trying to enter the market continues to increase. The reason why Canada is positioned to capitalize on this market is because they already operate under Health Canada’s stringent rules and regulations.
Cronos Products are Sold out of 200+ Pharmacies
Since October, Cronos Group has been distributing cannabis to Germany via its wholly owned subsidiary, Peace Naturals Project Inc.
In an interview with Benzinga, Cronos Group CEO Mike Gorenstein said, “We see Germany and other places in Europe as extremely attractive [markets] because cannabis is treated as a medicine. Like any other medicine, you receive a prescription for it from your doctor, and insurance is mandated to cover it.”
At the time of this interview, Gorenstein said that roughly 200 pharmacies in the European country currently sell their products. This is a very attractive aspect of the company and we expect to see this number increase as the market continues to mature and grow.
A Canadian Cannabis Producer to Watch
In late 2016, leading Canadian medical cannabis producer Canopy Growth (TWMJF) (CGC.TO) acquired MedCann GmbH Pharma and Nutraceuticals, a German-based pharmaceutical distributor that has placed Tweed-branded cannabis strains in German pharmacies. MedCann is federally licensed by the German Health Ministry to import, manufacture and distribute medical cannabis products.
Canopy's various production sites have a track record of producing consistent strains that yield reliable cannabinoid profiles harvest after harvest. This was an important aspect of the due diligence process as such consistency is a federal requirement for cannabis exports entering Germany.
Maricann Goes Public and Offers Leverage to Germany
Last week, Maricann Group (MARI.CN: CSE) secured $42.5 million in non-dilutive financing to further expand production in Germany. The capital came from a Vancouver-based firm that provides non-equity financing solutions for cannabis producers. In return, Maricann will provide the company the right to purchase 20% of production at an all-in cost plus 10% from this expansion in Germany.
Maricann will use the capital for its 150,000-sq. ft. expansion at its Ebersbach Facility and an additional 250,000 sq. ft. in a two-tiered cultivation plan. The capital will also be used for an outdoor hemp farm for cannabis that is high in cannabidiol (CBD).
The Ebersbach facility was built 20 years ago and is comprised of multiple individual clean rooms. The facility will not require too much capital to revamp and the company said the infrastructure needed to grow cannabis in an indoor secured environment is already in place.
In late April, Maricann commenced trading on the Canadian Securities Exchange. A few days later the company announced an Advisory Board for its German subsidiary. This is a company to watch. Maricann is a vertically integrated Canadian producer and distributor of medical cannabis. Since its inception, the company has been servicing a patient base of 8,000+ total registered patients.
https://technical420.com/cannabis-article/3-ways-capitalize-german-cannabis-market
Read more at http://www.stockhouse.com/companies/bullboard?symbol=c.mari&postid=26218004#jswfOm59xiIV5ZYq.99
That is actually a good point.!
Revenues didn't help.. The only thing going are lawsuits or a possible buyout. This is a tad bit worrisome.
But .. I will keep riding and see what happens?
$SFOR
I'm here.. I'm there.. I'm about.
Yes.. Those triples are headed for massive gains.
$SFOR